Under Medicare, CAR T-Cell Therapy Now Available Nationwide

The Centers for Medicare & Medicaid Services (CMS) have finalized nationwide coverage of chimeric antigen receptor (CAR) T-cell therapy, replacing the previous policy under which the decision of treatment coverage was left to Medicare's regional administrators. "As the first type of FDA-approved gene therapy, CAR T-cell therapies are an important scientific advancement in this promising new area of medicine and provide treatment options for some patients who had nowhere else to turn," c...
Continue reading

Cancer Treatment or Hospice Care—Why Choose?

Unfortunately, Medicare patients have to make the choice between receiving cancer treatment or hospice care; they cannot have both due to cost constraints. However, through the Veterans Health Administration (VHA), cancer treatment and hospice care can occur simultaneously if a patient opts for both. This concurrent treatment can be very valuable to patients and their loved ones; it is important to have the option to receive both treatments at once. "Often, Medicare patients with terminal cancer...
Continue reading

Prostate Cancer Treatment for Elderly Men Costs Medicare $1.2 Billion

The patients diagnosed with prostate cancer in the United States each year who are over the age of 70 cost Medicare an average of $1.2 billion over a 3-year period, according to a new study published in JAMA Oncology. Researchers used the nationwide, population-based Surveillance, Epidemiology, and End Results (SEER) Medicare-linked database to identify nearly 50,000 men 70 years or older diagnosed with localized prostate cancer between 2004 and 2007. When they determined the Medicare costs of e...
Continue reading

Copyright © 2020 i3 Health. All rights reserved.